ARCHIVES

DCT Board Pediatric Phase 1 Studies, Effort to Assess Obstacles To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 10 No. 27 | July 6, 1984

Download PDF Visit The Full Archive

Related Articles

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

Avon to Support Community Programs

January 7, 1994

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

Sprycell Approved for CML

November 5, 2010

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007